NORTHWEST BIOTHERAPEUTICS INC: accounts_payable
| Value | {"amount": 3808000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2011-12-31) |
| Status | current |
| Entity | NORTHWEST BIOTHERAPEUTICS INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T10:38:47.341585+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/b74cd6e3-c3ff-4d3b-8f79-8ccfc64a54e4
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001144204-12-050900 · Open the official SEC filing →Retrieved: 2026-08-19T10:38:47.341585+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001072379/accounts-payable/2011-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/b74cd6e3-c3ff-4d3b-8f79-8ccfc64a54e4
History
- supersedes {"amount": 2219000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} (evidence 0001144204-12-021574)